Linked Life Data

16755142

Source:http://linkedlifedata.com/resource/pubmed/id/16755142

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16755142rdf:typepubmed:Citationlld:pubmed
pubmed-article:16755142lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C0225897lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C2003888lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C0149721lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C0005823lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C0085580lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C1522602lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C1555029lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C2828008lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C0165703lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:16755142lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:16755142pubmed:issue2lld:pubmed
pubmed-article:16755142pubmed:dateCreated2006-6-9lld:pubmed
pubmed-article:16755142pubmed:abstractTextLeft ventricular hypertrophy is an independent risk factor for cardiovascular disease. We evaluated the effect of long-term and strict antihypertensive therapy with and without the angiotensin-converting enzyme inhibitor (ACEI) imidapril on left ventricular hypertrophy using a novel indicator of chronic burden on the left ventricle, the area under the blood pressure curve x the duration of high blood pressure (AUSBP and AUDBP), in patients with essential hypertension. The patients were divided into 2 groups: an ACEI group, in which imidapril was used in addition to antihypertensive drugs such as Ca channel blockers, beta-blockers, diuretics or angiotensin II antagonist; and a non-ACEI group, in which Ca channel blockers and diuretics were used. Systolic and diastolic blood pressures (SBP and DBP) were both maintained at below 140 and 90 mmHg, respectively, for 2 years. There was no significant difference in the left ventricular mass (LVM) assessed by echocardiography at baseline and that at 2 years of follow-up in the non-ACEI group. However, the LVM in the ACEI group was significantly decreased at 2 years of follow-up as compared to that at the baseline visit. There was no difference in the mean AUSBP and AUDBP between the ACEI and non-ACEI groups. Changes in the LVM were not correlated with the AUSBP or AUDBP in both the ACEI and non-ACEI groups. These findings suggest that the decrease in the LVM in the ACEI group was mediated through mechanisms other than the blood pressure lowering-effect and that AUSBP and AUDBP may be novel indicators of the long-term burden on the left ventricle.lld:pubmed
pubmed-article:16755142pubmed:languageenglld:pubmed
pubmed-article:16755142pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16755142pubmed:citationSubsetIMlld:pubmed
pubmed-article:16755142pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16755142pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16755142pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16755142pubmed:statusMEDLINElld:pubmed
pubmed-article:16755142pubmed:monthFeblld:pubmed
pubmed-article:16755142pubmed:issn0916-9636lld:pubmed
pubmed-article:16755142pubmed:authorpubmed-author:TakahashiMasa...lld:pubmed
pubmed-article:16755142pubmed:authorpubmed-author:UnoYoshihiroYlld:pubmed
pubmed-article:16755142pubmed:authorpubmed-author:NishigakiKazu...lld:pubmed
pubmed-article:16755142pubmed:authorpubmed-author:AraiMasazumiMlld:pubmed
pubmed-article:16755142pubmed:authorpubmed-author:MinatoguchiSh...lld:pubmed
pubmed-article:16755142pubmed:authorpubmed-author:FujiwaraHisay...lld:pubmed
pubmed-article:16755142pubmed:authorpubmed-author:KawasakiMasan...lld:pubmed
pubmed-article:16755142pubmed:issnTypePrintlld:pubmed
pubmed-article:16755142pubmed:volume29lld:pubmed
pubmed-article:16755142pubmed:ownerNLMlld:pubmed
pubmed-article:16755142pubmed:authorsCompleteYlld:pubmed
pubmed-article:16755142pubmed:pagination89-94lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:meshHeadingpubmed-meshheading:16755142...lld:pubmed
pubmed-article:16755142pubmed:year2006lld:pubmed
pubmed-article:16755142pubmed:articleTitleLong-term and strict blood pressure lowering by imidapril reverses left ventricular hypertrophy in patients with essential hypertension: an evaluation using a novel indicator of burden on the left ventricle.lld:pubmed
pubmed-article:16755142pubmed:affiliationSecond Department of Internal Medicine, Gifu University School of Medicine, Yanagido 1-1, Gifu 501-1911, Japan.lld:pubmed
pubmed-article:16755142pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16755142pubmed:publicationTypeClinical Triallld:pubmed